Investment Rating - The report rates the injection-based medical beauty industry as a new blue ocean market with significant growth potential [1]. Core Insights - The medical beauty industry is undergoing transformation driven by technological advancements and evolving aesthetic perceptions, with a focus on non-surgical procedures and natural results [1]. - The injection-based medical beauty market is experiencing rapid growth due to the increasing variety of procedures, high repurchase rates, and a market expansion that outpaces industry averages [1][5]. - The report highlights the emergence of new materials and innovations in traditional materials, which are enhancing the diversity of injection-based procedures [5][7]. Summary by Sections Injection-based Medical Beauty Concept and Classification - Injection-based medical beauty procedures are primarily categorized into hyaluronic acid, botulinum toxin, collagen, regenerative injectables, lipolytic injections, and thread lifting [2]. - According to ISAPS data, botulinum toxin leads globally with 8.878 million procedures, followed by hyaluronic acid with 5.565 million [2]. Market Heat Analysis - The synthetic regenerative materials are becoming investment hotspots, with significant funding directed towards companies in this sector [5]. - As of November 2024, 15 injectable products have received approval, primarily in the hyaluronic acid category [5]. Hyaluronic Acid Market Trends - Hyaluronic acid maintains a strong market position, with a growth rate of 29.1% from 2022 to 2023, indicating a "second growth curve" for the product [7]. Botulinum Toxin Market Trends - The market is expected to see a coexistence of natural and recombinant botulinum toxins, with recombinant products gaining traction due to their safety and customization potential [11]. Regenerative Materials Market Trends - The regenerative materials market is focusing on PLA and PCL, with hydroxyapatite emerging as a potential market leader [14]. Collagen Market Trends - The application of collagen in medical beauty is expanding, with a focus on types I and III for facial support and hydration [18]. User Preferences and Trends - The demand for skin improvement procedures is increasing, with a notable rise in interest in private care and hair transplant services [28][29]. - Users are becoming more discerning, prioritizing safety and effectiveness over cost, reflecting a shift in consumer behavior [31][34]. Injection-based Project Satisfaction and Repurchase Intent - Users express high satisfaction with injection-based procedures, particularly water light needles, which have the highest repurchase intent [41][42]. Market Expansion and Internationalization - Chinese companies are increasingly entering international markets, with a focus on hyaluronic acid and collagen products, while facing regulatory challenges [59].

注射类医美丨研究报告 核心摘要： 技术手段与审美认知共同引领医美行业变革。随着医美行业进入发展期，非手术项目选择逐渐丰富，"抗衰 老"成为消费者的核心诉求。注射类轻医美项目为精细化美容塑型提供技术支持，消费者在"变美"基础上更 加追求"自然"。随着新材料的不断出现、及传统材料的不断创新，注射类医美项目丰富度持续提升，满足多 元审美需求，加之其效果明显、恢复期短、可及性强，复购率不断上涨，案例数及市场规模呈现出超越行业 平均的增速。艾瑞认为，注射类医美市场将成为医美领域新蓝海。 注射类医美概念及分类 通过针剂注射实现微创美容，透明质酸和肉毒素二分天下 注射类医美项目是通过针剂注射方式实现微创美容效果的治疗手段，主要分为透明质酸类、肉毒素 类、胶原蛋白类、再生针剂类、溶脂针类和埋植线类。其中，医美注射类市场一直被透明质酸和肉 毒素二分天下，根据 ISAPS 数据， 2023 年全球注射类项目治疗次数排名中，肉毒素以 887.8 万例 居世界第一，玻尿酸以 556.5 万例居世界第二。此外，再生针剂、胶原蛋白针也是近年来的"明星 项目"，受到市场的狂热追捧。埋植线、溶脂针因技术不成熟、安全风险高等原因市场发展较为缓 ...

注射类医美丨研究报告 核心摘要： 技术手段与审美认知共同引领医美行业变革。随着医美行业进入发展期，非手术项目选择逐渐丰富，"抗衰 老"成为消费者的核心诉求。注射类轻医美项目为精细化美容塑型提供技术支持，消费者在"变美"基础上更 加追求"自然"。随着新材料的不断出现、及传统材料的不断创新，注射类医美项目丰富度持续提升，满足多 元审美需求，加之其效果明显、恢复期短、可及性强，复购率不断上涨，案例数及市场规模呈现出超越行业 平均的增速。艾瑞认为，注射类医美市场将成为医美领域新蓝海。 注射类医美概念及分类 通过针剂注射实现微创美容，透明质酸和肉毒素二分天下 注射类医美项目是通过针剂注射方式实现微创美容效果的治疗手段，主要分为透明质酸类、肉毒素 类、胶原蛋白类、再生针剂类、溶脂针类和埋植线类。其中，医美注射类市场一直被透明质酸和肉 毒素二分天下，根据 ISAPS 数据， 2023 年全球注射类项目治疗次数排名中，肉毒素以 887.8 万例 居世界第一，玻尿酸以 556.5 万例居世界第二。此外，再生针剂、胶原蛋白针也是近年来的"明星 项目"，受到市场的狂热追捧。埋植线、溶脂针因技术不成熟、安全风险高等原因市场发展较为缓 ...